By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Apricus Biosciences 

6330 Nancy Ridge Drive
Suite 103
San Diego  California  92121  U.S.A.
Phone: 858-222-8041 Fax: 858-866-0482


Drug Delivery

Company News
Apricus Biosciences (APRI) Appoints Barbara Troupin, M.D. As Chief Medical Officer 12/15/2014 8:11:26 AM
Apricus Biosciences (APRI) Announces First Patient Enrolled In Phase 2a Clinical Trial For Rayva In Patients With Raynaud's Phenomenon 12/4/2014 10:29:46 AM
Apricus Biosciences (APRI) Appoints Brian T. Dorsey As Chief Development Officer 12/2/2014 11:55:37 AM
Apricus Biosciences (APRI) Announces Third Quarter 2014 Financial Results And Provides Corporate Update 11/10/2014 8:13:13 AM
Apricus Biosciences (APRI) To Present At Three Upcoming Investor Conferences In November And December Of 2014 11/5/2014 10:13:28 AM
Apricus Biosciences (APRI) Announces Corporate Update And Third Quarter 2014 Financial Results Conference Call 11/4/2014 7:28:18 AM
Apricus Biosciences (APRI) Announces The Launch Of Its Novel Topical Treatment For Erectile Dysfunction In Belgium By Sandoz, Inc. 11/3/2014 8:53:35 AM
Forendo Pharma Licenses U.S. Fispemifene Rights To Apricus Biosciences (APRI) In Deal Worth $305 Million 10/20/2014 1:15:18 PM
Apricus Biosciences (APRI) Expands Development Pipeline With The In-Licensing Of U.S. Rights For Fispemifene, A Phase 2b Ready Asset, From Forendo Pharma Targeting Urological Conditions In Men 10/20/2014 6:22:45 AM
Apricus Biosciences (APRI) Announces Notice Of Allowance Of U.S. Patent Application For Rayva™ 10/13/2014 7:54:48 AM